Infectious Disease· Topic 7.17 Specific causative organisms· 7.17.3

Respiratory syncytial virus (RSV)

Respiratory syncytial virus is the leading cause of bronchiolitis and infant hospitalization for lower respiratory tract infection, peaking in fall and winter in children under two years. Diagnosis is clinical; management is supportive, and prevention now centers on universal infant immunoprophylaxis with nirsevimab or maternal RSV vaccination.

13 min read4 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    RSV is the dominant cause of bronchiolitis, an acute inflammatory illness of the small lower airways that primarily affects infants and children under 2 years of age; RSV causes roughly half of…

  • Epidemiology

    The most common cause of bronchiolitis in children younger than 2, causing winter and spring epidemics.

  • Risk factors

    Age under 6 months, the group at highest risk of severe disease and apnea.

  • Pathophysiology

    RSV, a paramyxovirus, infects respiratory epithelial cells via its surface fusion (F) glycoprotein, causing infected cells to fuse into multinucleated syncytia, the pathologic hallmark behind the virus's name.

  • Clinical features

    The illness begins as a mild upper respiratory infection (rhinorrhea, mild fever, cough) for 1 to 3 days before lower tract symptoms emerge.

  • Differential diagnosis

    Viral pneumonia (non-RSV or RSV pneumonia): overlapping tachypnea and hypoxia, but focal consolidation and a less prominent wheeze favor pneumonia over bronchiolitis.

  • Diagnosis

    Bronchiolitis is a clinical diagnosis (age under 2, viral prodrome, wheezing/crackles with tachypnea in season, as above); routine cases require no laboratory or radiologic workup.

  • Management

    Start with supportive care, the backbone of treatment for essentially all bronchiolitis: supplemental oxygen to an age-appropriate saturation target, nasal bulb or deep suctioning before feeds and…

  • Complications

    Respiratory failure, the most feared complication, from progressive airway obstruction and fatigue; the reason for close monitoring of respiratory rate and work of breathing.

  • Prognosis

    Most infants recover fully with supportive care alone, typically over 1 to 2 weeks, with cough sometimes persisting longer.

  • Prevention

    Universal infant immunoprophylaxis with nirsevimab, a long-acting RSV monoclonal antibody, is recommended for all infants entering their first RSV season: a single IM dose of 50 mg for infants under…

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.